Tevogen Bio Statistics
Share Statistics
Tevogen Bio has 175.05M shares outstanding. The number of shares has increased by 6.34% in one year.
| Shares Outstanding | 175.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 2.58% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 24.92M |
| Failed to Deliver (FTD) Shares | 18.46K |
| FTD / Avg. Volume | 0.11% |
Short Selling Information
The latest short interest is 3.69M, so 2.11% of the outstanding shares have been sold short.
| Short Interest | 3.69M |
| Short % of Shares Out | 2.11% |
| Short % of Float | 14.02% |
| Short Ratio (days to cover) | 0.09 |
Valuation Ratios
The PE ratio is -27322.43 and the forward PE ratio is null.
| PE Ratio | -27322.43 |
| Forward PE | null |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | -2643.71 |
| P/FCF Ratio | -1336.49 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tevogen Bio Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12, with a Debt / Equity ratio of -2.35.
| Current Ratio | 0.12 |
| Quick Ratio | 0.12 |
| Debt / Equity | -2.35 |
| Total Debt / Capitalization | 174.34 |
| Cash Flow / Debt | -0.84 |
| Interest Coverage | -0.03 |
Financial Efficiency
Return on equity (ROE) is 0.1% and return on capital (ROIC) is -0.94%.
| Return on Equity (ROE) | 0.1% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | -0.94% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -3.96K |
| Employee Count | 17 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -86.22% in the last 52 weeks. The beta is -1.03, so Tevogen Bio 's price volatility has been lower than the market average.
| Beta | -1.03 |
| 52-Week Price Change | -86.22% |
| 50-Day Moving Average | 1.43 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 61.12 |
| Average Volume (20 Days) | 17.23M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -8.84K |
| Net Income | -67.33K |
| EBITDA | 188.71K |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 8.84K in cash and 1.63M in debt, giving a net cash position of -1.62M.
| Cash & Cash Equivalents | 8.84K |
| Total Debt | 1.63M |
| Net Cash | -1.62M |
| Retained Earnings | -17.38M |
| Total Assets | 4.29M |
| Working Capital | -6.89M |
Cash Flow
In the last 12 months, operating cash flow was -1.38M and capital expenditures 0, giving a free cash flow of -1.38M.
| Operating Cash Flow | -1.38M |
| Capital Expenditures | 0 |
| Free Cash Flow | -1.38M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TVGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 0% |
| FCF Yield | -0.51% |
Analyst Forecast
Currently there are no analyst rating for TVGN.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -27.45 |
| Piotroski F-Score | 2 |